Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance

di Demarest, James, Underwood, Mark, St. Clair, Marty, Dorey, David, Brown, Dannae, Zolopa, Andrew
Pubblicato in AIDS Res Hum Retroviruses (2018)

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection

di Quercia, Romina, Perno, Carlo-Federico, Koteff, Justin, Moore, Katy, McCoig, Cynthia, St. Clair, Marty, Kuritzkes, Daniel
Pubblicato in J Acquir Immune Defic Syndr (2018)

Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects

di Zala, Carlos, St. Clair, Marty, Dudas, Kathleen, Kim, Joseph, Lou, Yu, White, Scott, Piscitelli, Steve, Dumont, Etienne, Pietropaolo, Keith, Zhou, Xiao-Jian, Mayers, Douglas
Pubblicazione 2012

Evolution of HIV Resistance Mutations in Patients Maintained on a Stable Treatment Regimen After Virologic Failure

di Goetz, Matthew Bidwell, Ferguson, Monique R., Han, Xueliang, McMillan, Greg, St. Clair, Marty, Pappa, Keith A., McClernon, Daniel R., O’Brien, William A.
Pubblicazione 2006

2840. Long-term Efficacy, Safety, and Durability of CAB and RPV as Two Drug Oral Maintenance Therapy: LATTE Week 312 Results

di Margolis, David, Sutton, Kenneth, De Vente, Jerome, LeBlanc, Roger, DeJesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt, Williams, Peter, Spreen, William
Pubblicato in Open Forum Infect Dis (2019)

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals...

di Hazen, Richard, Harvey, Robert, Ferris, Robert, Craig, Charles, Yates, Phillip, Griffin, Philip, Miller, John, Kaldor, Istvan, Ray, John, Samano, Vincente, Furfine, Eric, Spaltenstein, Andrew, Hale, Michael, Tung, Roger, St. Clair, Marty, Hanlon, Mary, Boone, Lawrence
Pubblicazione 2007

Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate V...

di Hazen, Richard J., Harvey, Robert J., St. Clair, Marty H., Ferris, Robert G., Freeman, George A., Tidwell, Jeffrey H., Schaller, Lee T., Cowan, Jill R., Short, Steven A., Romines, Karen R., Chan, Joseph H., Boone, Lawrence R.
Pubblicazione 2005

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor

di Ferris, Robert G., Hazen, Richard J., Roberts, Grace B., St. Clair, Marty H., Chan, Joseph H., Romines, Karen R., Freeman, George A., Tidwell, Jeffrey H., Schaller, Lee T., Cowan, Jill R., Short, Steven A., Weaver, Kurt L., Selleseth, Dean W., Moniri, Kelly R., Boone, Lawrence R.
Pubblicazione 2005

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

di Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St. Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.
Pubblicato in J Acquir Immune Defic Syndr (2020)